Stay updated on PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Sign up to get notified when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.

Latest updates to the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page
- Check2 days agoChange DetectedThe PRINCE study record is displayed with its eligibility criteria, treatment plan, outcomes, study locations, and related publications.SummaryDifference48%

- Check8 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA notice about NIH’s transition from the term “artificial intelligence” to “super intelligence” appears above the 403 error page.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision advanced from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision: v3.7.0 was added to the page, indicating an update to the site version. In addition, historical study record dates and navigation labels were removed as part of metadata cleanup.SummaryDifference18%

Stay in the know with updates to PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.